Pfizer on the hunt for a new CFO as Frank D'Amelio retires after nearly 15 years
Frank D’Amelio, Pfizer’s legendary chief financial officer of the last 15 years, would often say his job was about understanding the “rhythm of the numbers.” Now — as the company’s on track to drum up the largest single-year sales for a medical product ever — he’s hitting the exit on a high note.
D’Amelio is retiring from his position as CFO and executive vice president of global supply, Pfizer revealed Wednesday. CEO Albert Bourla has already begun an external search for his successor, and D’Amelio will stay on board through the transition.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.